COVID-19大流行期间急性心肌梗死管理:SCAI/ACC/ACEP立场声明
该立场声明由SCAI、ACC和ACEP联合制定,针对COVID-19大流行期间急性心肌梗死(AMI)患者的系统化管理提出推荐。声明聚焦于AMI的多样临床表现、医护人员的个人防护设备(PPE)、急诊科与导管室的作用以及区域STEMI救治系统。在可行且能及时提供的情况下,直接PCI仍是具备PCI能力医院中STEMI患者的标准治疗,由配备PPE的专家团队在专用导管室完成;在非PCI能力转诊医院或特定情况下可考虑溶栓策略。
要点
- 直接PCI仍是具备PCI能力医院中STEMI患者的标准治疗,需及时并由配备PPE的团队在专用导管室实施。
- 非PCI能力转诊医院或直接PCI无法执行时,可考虑基于溶栓的策略。
- COVID-19心血管表现复杂,包括AMI、模拟STEMI的心肌炎、应激性心肌病、非缺血性心肌病、冠脉痉挛或非特异性心肌损伤。
核心结论
- 在COVID-19大流行期间,直接PCI仍是具备PCI能力医院中STEMI患者的标准治疗,前提是能及时提供并由配备PPE的专家团队在专用导管室完成。
- 在非PCI能力转诊医院或直接PCI无法执行或不被认为是最佳选择的特定情况下,可考虑基于溶栓的策略。
研究设计与样本
- 本文为SCAI、ACC和ACEP联合发布的立场声明,旨在为COVID-19大流行期间AMI患者的系统化诊疗提供推荐。
主要发现
- COVID-19的心血管表现复杂,患者可表现为AMI、模拟STEMI的心肌炎、应激性心肌病、非缺血性心肌病、冠脉痉挛或非特异性心肌损伤。
- 美国人群中COVID-19患病率未知,且存在无症状传播风险。
- 声明聚焦于AMI的多样临床表现、医护人员的PPE、急诊科与急救医疗系统及心导管室的作用、区域STEMI救治系统四个方面。
关键数值与推荐
- 直接PCI是具备PCI能力医院中STEMI患者的标准治疗,需及时并由配备PPE的专家团队在专用导管室实施。
- 在非PCI能力转诊医院或直接PCI无法执行或不被认为是最佳选择的特定情况下,可考虑基于溶栓的策略。
临床怎么用
- 对STEMI患者,在具备PCI能力的医院应优先及时直接PCI,并确保团队配备PPE、使用专用导管室。
- 在非PCI能力医院或直接PCI不可行时,可评估溶栓策略。
- 需关注COVID-19患者可表现为模拟STEMI的心肌炎、应激性心肌病等,避免误诊。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 has resulted in a new and lethal disease termed coronavirus disease-2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, the majority of patients who need cardiovascular care for the management of ischemic heart disease may not be infected with this novel coronavirus. The objective of this document is to provide recommendations for a systematic approach for the care of patients with an acute myocardial infarction (AMI) during the COVID-19 pandemic. There is a recognition of two major challenges in providing recommendations for AMI care in the COVID-19 era. Cardiovascular manifestations of COVID-19 are complex with patients presenting with AMI, myocarditis simulating an ST-elevation myocardial infarction (STEMI) presentation, stress cardiomyopathy, non-ischemic cardiomyopathy, coronary spasm, or nonspecific myocardial injury, and the prevalence of COVID-19 disease in the U.S. population remains unknown with risk of asymptomatic spread. This document addresses the care of these patients focusing on 1) the varied clinical presentations; 2) appropriate personal protection equipment (PPE) for health care workers; 3) role of the Emergency Department, Emergency Medical System and the Cardiac Catheterization Laboratory; and 4) Regional STEMI systems of care. During the COVID-19 pandemic, primary PCI remains the standard of care for STEMI patients at PCI capable hospitals when it can be provided in a timely fashion, with an expert team outfitted with PPE in a dedicated CCL room. A fibrinolysis-based strategy may be entertained at non-PCI capable referral hospitals or in specific situations where primary PCI cannot be executed or is not deemed the best option.
引用
- Mahmud E, Dauerman HL, Welt FGP, et al. Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Statement From the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). J Am Coll Cardiol. 2020. PMID: 32330544. doi:10.1016/j.jacc.2020.04.039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。